Epilog
Epilog (operating as Clouds of Care) is a Belgium-based precision neuroscience company providing EEG-based biomarker services and a multimodal CNS platform to pharmaceutical and biotech sponsors running rare and complex central nervous system clinical trials.
- Company typePrivate
- Founded2016
- HeadquartersGhent, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Epilog does
Epilog, legally organized as Clouds of Care NV, is a Ghent, Belgium-based precision neuroscience company founded in 2016 that provides EEG-based biomarker services to pharmaceutical and biotech sponsors running central nervous system (CNS) clinical trials. The company's stated focus is on rare and complex CNS indications — championing in epilepsy and developmental and epileptic encephalopathies (DEEs), and pioneering in neurodegeneration including Alzheimer's disease — where objective neurophysiological endpoints are scarce. The platform ingests electrophysiology signals (EEG, PSG) alongside other digital health technology (DHT) modalities and applies multimodal AI processing to produce pharmacodynamic response biomarkers and clinical trial endpoints, with published case studies in Alzheimer's disease modification biomarkers and at-home EEG data collection in rare pediatric epilepsy.\n\nThe product surface is structured as a platform-plus-services architecture. The CNS Platform acts as a vendor-neutral integration layer connecting a curated network of DHT partners for data acquisition, aggregation, and analysis across multiple modalities. Layered on top is a Clinical Development Services offering organized around five service modules: multimodal endpoints advisory, DHT partner selection, data acquisition/aggregation/analysis, meaningful insights and endpoint validation, and interpretation and result reporting. The company holds ISO 13485 (medical device quality management) and ISO/IEC 27001 (information security) certifications from SGS with UKAS accreditation, and states GDPR compliance — meaningful procurement gates for regulated pharma trial sponsors.\n\nEpilog operates an enterprise go-to-market: revenue derives from professional services engagements with pharmaceutical and biotech customers conducting CNS clinical trials, with no public pricing and engagement initiated through a 'Get in touch' contact flow rather than self-serve. Named customers include Biohaven, ECET, GRIN Therapeutics, Ionis, Longboard Pharmaceuticals, Neurocrine, and UCB — all in pharma/biotech CNS drug development. The company employs 11–50 people (described as scientists, clinicians, engineers, and software developers backed by expert advisors), is privately held, is supported by Flanders Investment & Trade for international business development, and discloses no funding rounds, revenue figures, or M&A activity in the available data.
Epilog firmographics
Firmographics- Name
- Epilog
- Legal name
- Clouds of Care
- Website
- https://epilog.care
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Epilog (operating as Clouds of Care) is a Belgium-based precision neuroscience company providing EEG-based biomarker services and a multimodal CNS platform to pharmaceutical and biotech sponsors running rare and complex central nervous system clinical trials.
- Ownership category
- akta.pro rank
Epilog industry classification
Industry- Product category
- Clinical Trial Biomarker Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)Bioinformatics, Multi-Omics Data Analysis & Interpretation ServicesHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
Keywords
Where Epilog is headquartered
LocationHeadquarters
- HQ city
- Ghent
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
Epilog business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Clinical Development Services: Service-based revenue from providing CNS clinical trial support including multimodal endpoint advisory, digital health technology partner selection, data acquisition and analysis, and interpretation and result reporting
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Epilog product offering
Product offeringCore offering
Epilog (operating as Clouds of Care) delivers a multimodal AI-powered biomarker platform (the CNS Platform) and clinical development services that apply EEG-based biomarkers to CNS clinical trials for pharmaceutical and biotech sponsors. The company specializes in objective neurophysiological endpoints across epilepsy, developmental and epileptic encephalopathies (DEEs), Alzheimer's, and neurodegeneration, combining endpoint advisory, digital health technology partner selection, multimodal data acquisition/aggregation/analysis, endpoint validation, and interpretation/reporting. Its vendor-neutral platform connects a curated network of DHT solutions to gather and analyze multimodal CNS data, de-risking and streamlining CNS drug development.
Product overview
Clouds of Care offers a unified platform-plus-services architecture for precision neuroscience clinical development. The CNS Platform serves as the core infrastructure connecting a Curated Network of Solutions, while Clinical Development Services provides the operational framework with six integrated service modules: Multimodal Endpoints Advisory, Digital Health Technology Partner Selection, Data Acquisition/Aggregation/Analysis, Meaningful Insights & Endpoint Validation, and Interpretation & Result Reporting. Together, these components enable EEG-based biomarker services for rare and complex CNS clinical trials.
Differentiator
Problem solved
Functional benefit
Products and services
- CNS Platform A vendor-neutral platform that connects a curated network of digital health technology (DHT) solutions, enabling data acquisition, aggregation, and analysis of multimodal CNS data across EEG and other DHT modalities for pharmaceutical and biotech sponsors running CNS clinical trials.
- Clinical Development Services End-to-end clinical development services that de-risk and streamline CNS clinical trials through multimodal AI-powered biomarker services, including multimodal endpoint advisory, DHT partner selection, data acquisition/aggregation/analysis, meaningful insights and endpoint validation, and interpretation and result reporting. Targeted at pharmaceutical and biotech companies running CNS trials in epilepsy, DEEs, Alzheimer's, and neurodegeneration.
Quantifiable outcome
- Bridging pathology and clinical outcomes through functional brain measurement in early clinical development
Companies that use Epilog
Customer profileNamed customers7 records
Segments1 record
Ideal customer profiles1 record
Epilog technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature7 records
Epilog partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Flanders Investment & TradesupportingReceives support from Flanders Investment & Trade organization for international business development activities
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Epilog competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Epilog social profiles
Digital presenceEpilog compliance and trust
Trust signalCompliance3 records
Epilog financial estimates
Financial estimateRevenue estimate
Valuation estimate
Epilog leadership team
Management profileNumber of profiles
Epilog funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Epilog M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Epilog
What does Epilog do?
Epilog (operating as Clouds of Care) delivers a multimodal AI-powered biomarker platform (the CNS Platform) and clinical development services that apply EEG-based biomarkers to CNS clinical trials for pharmaceutical and biotech sponsors. The company specializes in objective neurophysiological endpoints across epilepsy, developmental and epileptic encephalopathies (DEEs), Alzheimer's, and neurodegeneration, combining endpoint advisory, digital health technology partner selection, multimodal data acquisition/aggregation/analysis, endpoint validation, and interpretation/reporting. Its vendor-neutral platform connects a curated network of DHT solutions to gather and analyze multimodal CNS data, de-risking and streamlining CNS drug development.
Is Epilog a public or private company?
Epilog is a private company. It is classified as unknown and is currently operating.
When was Epilog founded?
Epilog was founded in 2016. It employs 11 to 50 people.
Where is Epilog based?
Epilog is headquartered in Ghent, Belgium, in the Europe region.
How does Epilog make money?
One revenue line is on record: clinical Development Services.
Does Epilog have an API?
No public API is recorded for Epilog.
What industry is Epilog in?
Epilog's product category is Clinical Trial Biomarker Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 541714 and its SIC code is 8731.